Company Overview
About Celcuity
Celcuity is a biotechnology company headquartered in Minneapolis, Minnesota, United States. The company focuses on developing targeted therapies for cancer patients by providing insights into oncogenic pathways. Celcuity's lead candidate is gedatolisib, a dual PI3K - mTOR inhibitor, which is being developed to disrupt the oncogenic process and improve outcomes for cancer patients.
More Companies in Minnesota
Browse all companies in Minnesota →
Frequently Asked Questions about Celcuity
Social Profiles
Key Decision Makers
Monica Romero Clinical Trial Manager